Glycaemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study

被引：0

作者：

Halter, J.

Kennedy, L.

Miller, M.

Herman, W.

机构：

[1] Univ Michigan, Geriatr Ctr, Div Geriatr Med, Ann Arbor, MI 48109 USA

[2] Univ Florida, Dept Med, Gainesville, FL USA

[3] Sanofi Aventis US, Bridgewater, MA USA

[4] Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA

来源：

DIABETOLOGIA | 2006年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0987

引用

页码：602 / 603

页数：2

共 50 条

[21] ACHIEVEMENT OF GLYCAEMIC TARGETS WITH CANAGLIFLOZIN IN TRIPLE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Diels, J.
Schubert, A.
Hamilton, G.
Canovatchel, W.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
[22] Comparison of the Effects of Insulin Detemir (IDet) and Insulin Glargine (IGlar) in Patients With Type 2 Diabetes (T2DM) in Turkey
Damci, Taner
Emral, Rifat
Svendsen, Anne Louise
Balkir, Tanzer
Vora, Jiten
[J]. DIABETES, 2013, 62 : A653 - A653
[23] Glycaemic goal and comorbidities of elderly patients with type 2 diabetes mellitus in the US
Bron, M.
Shaya, F. T.
Yan, X.
Pandya, P. J.
Baran, R. W.
[J]. DIABETOLOGIA, 2008, 51 : S179 - S180
[24] Modelling HbA1c Trajectory in Patients with Type 2 Diabetes Mellitus (T2DM)
Mcewan, Phil
Fellows, Jonathan
Yapp, Rhiannon
Bergenheim, Klas
Qin, Lei
Varol, Nebibe
Bennett, Hayley
Gordon, Jason
[J]. DIABETES, 2016, 65 : A322 - A322
[25] Health-related quality of life (HRQL) in patients with type 2 diabetes (T2DM), receiving add-on therapy with insulin glargine (GLAR) or pioglitazone (PIO)
Oster, G.
Meneghini, L. F.
Schwartz, S.
Zhang, Q.
[J]. DIABETES, 2006, 55 : A477 - A477
[26] Oral Antidiabetic Drug (OAD) and Insulin (I) Treatment Patterns in Treatment Naive Type 2 Diabetes Mellitus (T2DM) Patients with High Baseline (BL) Hemoglobin A1c (A1C)
Krishnarajah, Girishanthy
Amin, Shahla
Balar, Bharvi A.
[J]. DIABETES, 2010, 59 : A567 - A567
[27] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
Ross, Stuart A.
Haak, Thomas
Patel, Sanjay
Thiemann, Sandra
Schumacher, Helmut
Meinicke, Thomas
[J]. DIABETES, 2014, 63 : A277 - A277
[28] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
Byrne, R.
Curley, S.
Ahmed, K.
Ahmed, M.
Gibney, J.
Mcgillicuddy, F.
[J]. ATHEROSCLEROSIS, 2020, 315 : E65 - E66
[29] Saxagliptin (SAXA) Reduces A1C and Is Well Tolerated in Patients With Type 2 Diabetes (T2DM) and Albuminuria
Bonora, Enzo
Cook, William
Bryzinski, Brian
Hirshberg, Boaz
Allen, Elsie
[J]. DIABETES, 2013, 62 : A669 - A669
[30] Effects of Insulin Glargine vs Thiazolidinediones on Glycemic and Lipid Variables in Type 2 Diabetes Mellitus (T2DM): The Impact of Obesity
Meneghini, Luigi F.
Rosenberg, Noah
Hollander, Priscilla
Rosenstock, Julio
Riddle, Matthew C.
Nesto, Richard W.
Dandona, Paresh
[J]. DIABETES, 2009, 58 : A523 - A523

← 1 2 3 4 5 →